A single-institution prospective study was conducted to evaluate hearing loss rate after intensity modulated radiotherapy with concomitant cisplatin-based chemotherapy (CRT) for locally advanced head and neck cancer and identify cochlear dosimetric parameters associated with hearing loss risk.

Hearing loss after cisplatin-based chemoradiotherapy for locally advanced head and neck cancer: a prospective single-institution study

DE Vincentiis, Marco
Secondo
;
D'Urso, Pasqualina;Musacchio, Angela;Maiuri, Veronica;Zaccaro, Lucy;Ralli, Massimo;Marchetti, Claudia;Turchetta, Rosaria;Tombolini, Vincenzo
Penultimo
;
DE Felice, Francesca
Ultimo
2022

Abstract

A single-institution prospective study was conducted to evaluate hearing loss rate after intensity modulated radiotherapy with concomitant cisplatin-based chemotherapy (CRT) for locally advanced head and neck cancer and identify cochlear dosimetric parameters associated with hearing loss risk.
File allegati a questo prodotto
File Dimensione Formato  
Musio_Hearing loss_2022.pdf

solo gestori archivio

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 3.17 MB
Formato Adobe PDF
3.17 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11573/1651664
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact